Latest

SSRIs

·October 30, 2025·6 min read

Common Antidepressant Eases Core Symptoms Within Two Weeks

A new analysis of the PANDA clinical trial reveals that sertraline, one of the most prescribed antidepressants, improves key emotional symptoms of depression—such as sadness, self-loathing, and suicidal thoughts—within just two weeks of treatment. Using network analysis to assess individual symptoms, researchers found that the drug also eased anxiety early on, while somatic effects like fatigue and low libido appeared but later stabilized.

This shows a woman, hearts, a brain, and brain waves.

Featured Neuroscience Psychology

·October 13, 2025·6 min read

EEG Test May Reveal Who Loses Libido on Antidepressants

A new study reveals that serotonin levels in the brain, measured using a simple EEG-based test, can predict who will experience sexual side effects from SSRI antidepressants. Researchers found that people with higher serotonin activity before treatment were significantly more likely to have difficulty reaching orgasm during antidepressant use.

Featured Genetics Neuroscience Psychology

·July 19, 2025·7 min read

Why Antidepressants Work Better for Some

A meta-analysis of gene expression data from humans and rodents reveals key biological pathways influencing response to the antidepressant fluoxetine. The study highlights the role of immune-related pathways, including toll-like receptor signaling, and neural signal transduction mechanisms in distinguishing responders from non-responders.

Featured Neuroscience Psychology

·July 7, 2025·5 min read

Timing of Prozac Treatment Shapes Lasting Mood, Brain Changes

New research reveals that the developmental timing of fluoxetine (Prozac) treatment profoundly influences long-term mood and brain function. In a rodent model, early postnatal treatment in males led to persistent anxiety and depression-like behaviors, while adolescent treatment reduced these behaviors.

Featured Neurology Neuroscience

·May 30, 2025·4 min read

SSRIs Restore Brain Function in Alzheimer’s

A new study suggests that SSRIs, commonly prescribed antidepressants, may reduce biological markers of Alzheimer’s disease. In a cohort of 191 individuals, AD patients on SSRIs had lower levels of plasma phosphorylated tau-181, a key indicator of disease severity.

Featured Neuroscience Psychology

·May 7, 2025·8 min read

SSRI Exposure in the Womb May Rewire Brain Circuits

New research suggests that prenatal exposure to SSRIs may alter brain development in ways that increase the risk of depression and anxiety later in life. Using mice and human data, scientists found that early-life SSRI exposure heightened activity in brain fear circuits, a pattern not observed in offspring of depressed mothers who did not take SSRIs.

This shows a head and psychedelic swirls.

Featured Neuroscience Psychology

·September 22, 2024·7 min read

Psilocybin Shows Greater Long-Term Benefits Over SSRI for Depression

A study comparing psilocybin to the SSRI escitalopram found both drugs improved depressive symptoms similarly over six months, but psilocybin offered additional psychosocial benefits. Patients taking psilocybin reported a greater sense of meaning, psychological connectedness, and improved social functioning. These results suggest psilocybin could provide a more holistic treatment option for depression, addressing both symptoms and overall well-being. While promising, psilocybin remains experimental and is only administered in controlled environments.

Featured Neuroscience Psychology

·June 6, 2024·4 min read

How Antidepressants Treat Major Depression

Researchers have developed a new framework explaining how antidepressants, like SSRIs, treat major depressive disorder (MDD) by restoring brain connectivity rather than correcting a serotonin imbalance. Their findings emphasize the continued importance of these medications despite shifting public opinion. This new understanding could improve patient-clinician conversations about depression treatment.

Featured Neuroscience

·May 31, 2024·3 min read

SSRIs Reveal New Potential Beyond Depression Treatment

A new study uncovers a key biological process targeted by SSRIs, suggesting new clinical applications. The study found that SSRIs affect membrane trafficking in cells, which might explain their broader effects. Remarkably, a single dose of fluvoxamine in mice enabled drug delivery across the blood-brain barrier. This discovery could lead to SSRIs aiding in the delivery of drugs for conditions like dementia.

Featured Neuroscience Psychology

·February 16, 2024·3 min read

Antidepressants Impact Brain Development

Using antidepressants during pregnancy, specifically fluoxetine (found in Prozac and Sarafem), can significantly affect a child's brain development, particularly in the prefrontal cortex, potentially increasing the risk of mental health disorders later in life. The research highlights how serotonin, boosted by fluoxetine, directly impacts the development of synaptic connections in the prefrontal cortex, a critical area for high-order cognitive functions.

Featured Neuroscience Psychology

·August 29, 2023·6 min read

Treating Mom’s Postnatal Depression with SSRIs Also Boosts Child Behavior

A new study found that treating postnatal depression with selective serotonin reuptake inhibitors (SSRIs) benefits not just mothers but also their children. The study, which analyzed data from over 61,000 mothers and their children, shows that SSRI treatment led to better outcomes up to five years after childbirth.

Featured Neuroscience Psychology

·January 23, 2023·5 min read

Study Explains Emotional ‘Blunting’ Caused by Common Antidepressants

SSRI antidepressants can make users less sensitive to rewards, resulting in emotional blunting many users experience. The findings provide new evidence for the role serotonin plays in reinforcement learning.

1 2 3 … 10

SSRIs

Common Antidepressant Eases Core Symptoms Within Two Weeks

EEG Test May Reveal Who Loses Libido on Antidepressants

Why Antidepressants Work Better for Some

Timing of Prozac Treatment Shapes Lasting Mood, Brain Changes

SSRIs Restore Brain Function in Alzheimer’s

SSRI Exposure in the Womb May Rewire Brain Circuits

Psilocybin Shows Greater Long-Term Benefits Over SSRI for Depression

How Antidepressants Treat Major Depression

SSRIs Reveal New Potential Beyond Depression Treatment

Antidepressants Impact Brain Development

Treating Mom’s Postnatal Depression with SSRIs Also Boosts Child Behavior

Study Explains Emotional ‘Blunting’ Caused by Common Antidepressants

Study Challenges Myths About Self-Centeredness

Blood Sugar Patterns Strongly Linked to Sleep Quality

AI Brain Model Reveals How Fear Works in Real Life

Blood Transfusions May Accelerate Alzheimer’s Progression

Subscribe